OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 274.55

Change

-0.05 (-0.02)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.34 (-1.26%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.70 (-1.37%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.32 (-1.48%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.94 (-0.18%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.75 (-1.37%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.01 (-0.01%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.20 (-1.31%)

USD 56.18B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.09 (-0.10%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.08 (-0.09%)

USD 51.63B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.33% 82% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.33% 80% B- 67% D+
Trailing 12 Months  
Capital Gain 9.84% 58% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.84% 56% F 57% F
Trailing 5 Years  
Capital Gain 43.77% 69% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.77% 68% D+ 56% F
Average Annual (5 Year Horizon)  
Capital Gain 6.14% 69% C- 68% D+
Dividend Return 6.14% 68% D+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.86% 60% D- 81% B-
Risk Adjusted Return 62.25% 87% B+ 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike